Ordinary Index Rebalancing in the Solactive Health Care Technology Index | March 2022

In the ordinary rebalance the following composition will be implemented effective open 10.03.2022:

ABBOTT LABORATORIES
AMGEN INC
BIONTECH SE
GETINGE AB CLASS B
GILEAD SCIENCES INC
GLAXOSMITHKLINE PLC-SPON ADR
JOHNSON & JOHNSON
MEDTRONIC PLC
MODERNA INC
NOVAVAX INC
PFIZER INC
QIAGEN NV
REGENERON PHARMACEUTICALS
SANOFI SA
SINOPHARM GROUP CO LTD
TAKEDA PHARMACEUTICAL
THERMO FISHER SCIENTIFIC INC
VIR BIOTECHNOLOGY INC
WEST PHARMACEUTICAL SERVICES INC